189 related articles for article (PubMed ID: 29850833)
1. Two-Year Clinical, Cerebral Hemodynamic, and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion: A Prospective Cohort Study.
Miyoshi K; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
Neurosurgery; 2019 Jun; 84(6):1233-1241. PubMed ID: 29850833
[TBL] [Abstract][Full Text] [Related]
2. Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion.
Kitakami K; Kubo Y; Yabuki M; Oomori D; Takahashi T; Igarashi S; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis; 2022; 51(2):158-164. PubMed ID: 34518462
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
[TBL] [Abstract][Full Text] [Related]
4. Impact of cerebral blood flow changes due to arterial bypass surgery on cognitive function in adult patients with symptomatic ischemic moyamoya disease.
Yanagihara W; Chida K; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Ogasawara K
J Neurosurg; 2018 Dec; 131(6):1716-1724. PubMed ID: 30554180
[TBL] [Abstract][Full Text] [Related]
5. Angiographic, Cerebral Hemodynamic, and Cognitive Outcomes of Indirect Revascularization Surgery Alone for Adult Patients With Misery Perfusion due to Ischemic Moyamoya Disease.
Kimura K; Kubo Y; Dobashi K; Katakura Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Kawamura T; Ogasawara K
Neurosurgery; 2022 Jun; 90(6):676-683. PubMed ID: 35311740
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Medical Management Alone for Adult Patients with Cerebral Misery Perfusion Due to Ischemic Moyamoya Disease.
Ogasawara K; Uchida S; Akamatsu Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Kubo Y
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106588. PubMed ID: 35671656
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Cognitive Changes after Revascularization Surgery in Adult Patients with Ischemic Moyamoya Disease.
Uchida S; Kubo Y; Oomori D; Yabuki M; Kitakami K; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Cerebrovasc Dis Extra; 2021; 11(3):145-154. PubMed ID: 34808627
[TBL] [Abstract][Full Text] [Related]
8. Angiographic disease progression in medically treated adult patients with ischemic moyamoya disease without cerebral misery perfusion: supplementary analysis of a 5-year prospective cohort.
Oomori D; Kubo Y; Yabuki M; Kitakami K; Fujiwara S; Yoshida K; Kobayashi M; Terasaki K; Ogasawara K
Neurosurg Rev; 2022 Apr; 45(2):1553-1561. PubMed ID: 34689243
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort.
Ando S; Tsutsui S; Miyoshi K; Sato S; Yanagihara W; Setta K; Chiba T; Fujiwara S; Kobayashi M; Yoshida K; Kubo Y; Ogasawara K
Neurol Res; 2019 May; 41(5):480-487. PubMed ID: 30774013
[TBL] [Abstract][Full Text] [Related]
10. Effect of the addition of
Ogasawara K; Takahashi T; Igarashi S; Yabuki M; Omori D; Akamatsu Y; Chida K; Kobayashi M; Fujiwara S; Terasaki K
Ann Nucl Med; 2023 May; 37(5):280-288. PubMed ID: 36805493
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
Setta K; Kojima D; Shimada Y; Yoshida J; Oshida S; Fujimoto K; Tsutsui S; Chiba T; Fujiwara S; Terasaki K; Ogasawara K
Ann Nucl Med; 2018 Nov; 32(9):611-619. PubMed ID: 30030783
[TBL] [Abstract][Full Text] [Related]
12. Recovery of Cortical Neurotransmitter Receptor Function and Its Impact on Cognitive Improvement after Indirect Revascularization Surgery Alone for Adult Patients with Ischemic Moyamoya Disease:
Yasuda S; Katakura Y; Kubo Y; Dobashi K; Kimura K; Fujiwara S; Chida K; Akamatsu Y; Kobayashi M; Yoshida K; Terasaki K; Ogasawara K
World Neurosurg; 2022 Aug; 164():e1135-e1142. PubMed ID: 35660480
[TBL] [Abstract][Full Text] [Related]
13. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Katakura Y; Kubo Y; Dobashi K; Kimura K; Fujiwara S; Chida K; Kobayashi M; Yoshida K; Terasaki K; Ogasawara K
Acta Neurochir (Wien); 2022 Apr; 164(4):1037-1045. PubMed ID: 35122551
[TBL] [Abstract][Full Text] [Related]
14. Reconsideration of Hemodynamic Cerebral Ischemia Using Recent PET/SPECT Studies.
Nakagawara J
Acta Neurochir Suppl; 2016; 123():99-108. PubMed ID: 27637635
[TBL] [Abstract][Full Text] [Related]
15. Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease.
Sato S; Kojima D; Shimada Y; Yoshida J; Fujimato K; Fujiwara S; Kobayashi M; Kubo Y; Yoshida K; Terasaki K; Tsutsui S; Miyoshi K; Ogasawara K
J Cereb Blood Flow Metab; 2018 Jun; 38(6):1021-1031. PubMed ID: 29383984
[TBL] [Abstract][Full Text] [Related]
16. Development of cerebral microbleeds and its impact on cognitive function in adult patients receiving medical management alone for ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort.
Yabuki M; Kubo Y; Kitakami K; Oomori D; Fujiwara S; Yoshida K; Kobayashi M; Ogasawara K
Neurol Res; 2022 Dec; 44(12):1104-1112. PubMed ID: 35975947
[TBL] [Abstract][Full Text] [Related]
17. De Novo Cerebral Microbleeds and Cognitive Decline in Cerebral Hyperperfusion After Direct Revascularization for Adult Moyamoya Disease.
Dobashi K; Kubo Y; Kimura K; Katakura Y; Chida K; Kobayashi M; Yoshida K; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106166. PubMed ID: 34768143
[TBL] [Abstract][Full Text] [Related]
18. Postoperative executive function in adult moyamoya disease: a preliminary study of its functional anatomy and behavioral correlates.
Lei Y; Li YJ; Guo QH; Liu XD; Liu Z; Ni W; Su JB; Yang H; Jiang HQ; Xu B; Gu YX; Mao Y
J Neurosurg; 2017 Feb; 126(2):527-536. PubMed ID: 27058195
[TBL] [Abstract][Full Text] [Related]
19. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
[TBL] [Abstract][Full Text] [Related]
20. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
